BioInvent International Logo
SE0015244520
A2QJRW
BINV.ST

BioInvent International

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, BioInvent International had revenue of €951.97K and net profit of -€10.49M
(EUR) September 2026
YoY
Revenue 951.97K 216.85%
Gross profit 951.97K -
Net profit -10.49M 10.29%
EBITDA -10.26M 8.82%

Fundamentals

Metric Value
Market capitalization
€17.27M
Number of shares
65.8M
52-week high/low
€3.13 - €0.17
Dividends No
Beta
0.02
P/E ratio
-0.39
PEG ratio
0.01
P/B ratio
0.95
P/S ratio
4.80

Company profile

BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 in solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumor-associated myeloid cells; partnership and collaboration with Transgene to co-develskylinop multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck for the clinical development of BI-1808. The Company was incorporated in 1996 and is based in Lund, Sweden.

Name
BioInvent International
CEO
Martin Welschof
Headquarters Lund, sn
Sweden
Website
IPO
06/12/2001
Employees 107

Ticker symbols

Exchange Symbol
Sto
BINV.ST
Pnk
BOVNF
Frankfurt
BIX0.F
Düsseldorf
BIX0.DU
London
0H22.L
Stockholm
BINV.ST
München
BIX0.MU
🍪

Parqet  uses cookies. Learn more